Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 81211 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

In-class evaluations ............................................................. 40,000 1 40,000 .05 2,000 

Mail/Telephone surveys ....................................................... 12,000 1 12,000 .25 3,000 

Focus groups ....................................................................... 250 1 250 1.50 375 

Total .............................................................................. 52,250 ........................ 52,250 ........................ 5,375 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2020–27500 Filed 12–14–20; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–New] 

Agency Information Collection 

Request; 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Office of the Secretary (OS), Department 

of Health and Human Services, is 

announcing it has submitted to the 

Office of Management and Budget 

(OMB) for review and clearance the 

following collection of information. 

DATES: Comments on the ICR must be 

received on or before January 14, 2021. 

ADDRESSES: Submit your comments to 

OIRA_submission@omb.eop.gov or via 

facsimile to (202) 395–5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990–New and project title for 

reference. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, OS/ 

DHHS has submitted the following 

proposed collection of information to 

OMB for review and clearance. 

OMB No. 0990–New—HHS 

Teletracking COVID–19 Portal 

OMB Control Number 

Abstract: The data collected through 

this ICR informs the Federal 

Government’s understanding of disease 

patterns and furthers the development 

of policies for prevention and control of 

disease spread and impact related to the 

2019 Novel Coronavirus (COVID–19). 

One of the most important uses of the 

data collected through this ICR is to 

determine critical allocations of limited 

supplies (e.g., protective equipment and 

medication). For instance, this 

collection has been used to distribute 

Remdesivir, a vital therapeutic that HHS 

distributes to the American healthcare 

system, via distinct data calls on regular 

intervals. As of July 10, HHS reduced 

the number requests for data from 

hospitals to support allocations of 

Remdesivir. HHS has stopped sending 

out one-time requests for data to aid in 

the distribution of Remdesivir or any 

other treatments or supplies. This 

consolidated daily reporting is the only 

mechanism used for the distribution 

calculations, and daily reports are 

needed to ensure accurate calculations. 

Type of Respondent: We acknowledge 

the burden placed on many hospitals, 

including resource constraints, and have 

allowed for some flexibilities, such as 

back-submissions or submitting every 

business days, with the understanding 

that respondents may not have 

sufficient staff working over the 

weekend. It is our belief that collection 

of this information daily is the most 

effective way to detect outbreaks and 

needs for Federal assistance over time, 

by hospital and geographical area, and 

to alert the appropriate officials for 

action. It’s requested that 5,500 

hospitals, submit data daily on the 

number of patients tested for COVID–19, 

as well as information on bed capacity 

and requirements for other supplies. 

The HHS Teletracking COVID–19 

Portal (U.S. Healthcare COVID–19 

Portal) includes some data that were 

initially submitted by hospitals to HHS 

through CDC’s National Healthcare 

Safety Network (NHSN) COVID–19 

Module (OMB Control No. 0920–1290, 

approved 03/26/2020). Over the last 

several months time, the guidance for 

which data elements should be sent to 

HHS and through which method was 

updated at the request of the White 

House Coronavirus Task Force and 

other leaders to better inform the 

response. 

ESTIMATED ANNUALIZED BURDEN HOURS

Number of 

respondents 

Form name 

(electronic portal) 

Number of 

responses per 

respondents 

Total annual 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

5500 ............ HHS Teletracking COVID–19 Portal ...................................... 365 2,007,500 1.75 3,513,125 

81212 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices 

Terry Clark, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2020–27473 Filed 12–14–20; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Network of 

Older Persons with Superior Cognition 

Performance. 

Date: January 14, 2021. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, Two 

Democracy Plaza, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (301) 496–9666, 

parsadaniana@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alzheimer’s 

Disease Drug Development. 

Date: January 22, 2021. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (301) 496–9666, 

parsadaniana@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Neural 

Network Dysfunction in AD. 

Date: February 2, 2021. 

Time: 11:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (301) 496–9666, 

parsadaniana@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 9, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–27494 Filed 12–14–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Oxidative 

Stress. 

Date: January 19, 2021. 

Time: 12:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Nijaguna Prasad, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, (301) 496–9667, 

nijaguna.prasad@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Pepper Center 

May 2021 Council. 

Date: February 26, 2021. 

Time: 7:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, Two 

Democracy Plaza, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Anita H. Undale, MD, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building, Suite 2W200, 7201 Wisconsin 

Avenue, Bethesda, MD 20892, (301) 827– 

7428, anita.undale@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 9, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–27469 Filed 12–14–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; RFA DK20–016: 

Human Pancreas Analysis Program for Type 

1 Diabetes—HPAP–T1D. 

Date: February 1, 2021. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Video 

Meeting). 

Contact Person: Najma S. Begum, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7349, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8894, 

begumn@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Small Business 

Applications T1D Open/Closed Loop 

Platforms. 

Date: February 12, 2021.